LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces a Standby Equity Purchase Agreement (SEPA) for up to $30 million worth of common stock over the course of 36 months.
VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, reports the voting results from its Annual General and Special Meeting of shareholders (the “Meeting”) held earlier today.
SAN FRANCISCO, July 31, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2025.
...
EDINBURG, Va., July 31, 2025 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced second quarter 2025 financial and operating results.
Growth rate reaccelerates to 16% for the Coveo core platform(2)Generative AI solutions drove ~50% of new business during the quarterBroadens relationship with SAP
Coveo reports...
Growth rate reaccelerates to 16% for the Coveo core platform(2)Generative AI solutions drove ~50% of new business during the quarterBroadens relationship with SAP
Coveo reports...
Landmark 30th Anniversary EnerCom Denver – The Energy Investment Conference Announces Energy Transition and Emerging Technology Session Schedule
Qualified Investors and Analysts Can Register at...
CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) -- Reconnaissance Energy Africa Ltd. (the “Company” or “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that the Kavango West 1X exploration well is currently drilling and provides a corporate update on ongoing operations.
Transaction facilitated by Concentro
FAIRMONT, N.C., July 30, 2025 /PRNewswire/ -- T&H Farms, a family-owned farm, today announced the successful sale of clean energy tax...
SACRAMENTO, Calif., July 29, 2025 /PRNewswire/ -- The California State Educator Workforce Collaborative, a first-ever partnership of 12 education agencies and institutions, today released a...
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce that its board of directors has approved the grant of an aggregate of 540,000 stock options (the “Options”) to certain consultants, employees, officers and directors of the Company pursuant to the Company’s Long Term Incentive Plan.